Aspen Neuroscience
CA - San DiegoBiotechnology
Focus: Aspen Neuroscience is a public-stage biotechnology company developing autologous iPSC-derived neuron replacement therapy, focused on neurodegenerative diseases with a lead program in Parkinson's Disease. The company represents an emerging player in the highly specialized cell therapy segment.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Aspen Neuroscience
AI assessmentNot HiringNo open roles listed right now. Follow Aspen Neuroscience to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ANPD001
Parkinson DiseaseClinical Trials (1)
NCT06344026Phase 1/2a Study of ANPD001 in Parkinson Disease
Phase 1Help build intelligence for Aspen Neuroscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.